Re: Intro to revised R21 Crea, Catharine 28 Jun 2006 13:22 EST
Check the PA. I have just run across two PA's for R21 proposals that limit the introduction to one page in addition to limiting the research plan to 15. Catharine Crea Associate Dean for Research Administration New York Medical College Valhalla, New York 10595 (914) 594-4480 phone (914) 594-4694 fax -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Regeane Villarson Sent: Wednesday, June 28, 2006 12:33 PM To: xxxxxx@hrinet.org Subject: Re: [RESADM-L] Intro to revised R21 Another issue for the revised R21: We just submitted a revised R21 and it bounced back with an error stating that the introduction can not be more than 1 PAGE. This is incorrect. As far as I know, the PI still has 3 pages for their intro. The SF 424 R&R Application Guide also confirms the three page limit (page I-18). I sent an e-mail to the help desk regarding this issue. Has any one else received this error? Best, Regeane Villarson, MBA Assistant Manager Office of Research and Sponsored Programs New Jersey Medical School 973-972-8649 972-972-3585 (fax) >>> xxxxxx@LHS.ORG 06/28/06 12:03 PM >>> We have an investigator resubmitting an R21 for July 1 who has raised an interesting question regarding the Introduction in the SF424RR. She and others in the past have typically referenced page numbers in the Research Plan to note some changes or revisions. Since page numbers are now not allowed, any suggestions as to how to handle this? Thanks in advance. The collective talent and wisdom on this LISTSERV is greatly appreciated. Regards, Steve Hunter Legacy Research Portland, Oregon IMPORTANT NOTICE: This communication, including any attachment, contains information that may be confidential or privileged, and is intended solely for the entity or individual to whom it is addressed. If you are not the intended recipient, you should contact the sender and delete the message. Any unauthorized disclosure, copying, or distribution of this message is strictly prohibited. Nothing in this email, including any attachment, is intended to be a legally binding signature. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================